Abstract
Recent health care legislation in the United States has turned considerable focus to comparative effectiveness research (CER) domestically, though it has been a topic of discussion internationally for many years. Without a fully comprehensive and consistent definition of CER developed, much uncertainty and confusion surrounds its utilization. In addition, contention exists regarding the incorporation of cost and economic considerations as a component of CER. This discussion includes various suggested definitions of CER, methodological considerations, legislation and utilization, and the role of cost-effectiveness evaluations in CER.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 27-35 |
| Number of pages | 9 |
| Journal | Pharmaceuticals Policy and Law |
| Volume | 14 |
| Issue number | 1 |
| DOIs | |
| State | Published - 2012 |
Fingerprint
Keywords
- Comparative effectiveness research (CER)
- effectiveness
- health technology assessment
- outcomes
- pharmacoeconomics
ASJC Scopus subject areas
- Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
- Health Policy
Cite this
Comparative effectiveness research : The translational science of comparing the what, how, when, in whom, by whom, and why of treatment effectiveness. / Olvey, Eleanor L.; MacDonald, Karen; Abraham, Ivo L.
In: Pharmaceuticals Policy and Law, Vol. 14, No. 1, 2012, p. 27-35.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Comparative effectiveness research
T2 - The translational science of comparing the what, how, when, in whom, by whom, and why of treatment effectiveness
AU - Olvey, Eleanor L.
AU - MacDonald, Karen
AU - Abraham, Ivo L
PY - 2012
Y1 - 2012
N2 - Recent health care legislation in the United States has turned considerable focus to comparative effectiveness research (CER) domestically, though it has been a topic of discussion internationally for many years. Without a fully comprehensive and consistent definition of CER developed, much uncertainty and confusion surrounds its utilization. In addition, contention exists regarding the incorporation of cost and economic considerations as a component of CER. This discussion includes various suggested definitions of CER, methodological considerations, legislation and utilization, and the role of cost-effectiveness evaluations in CER.
AB - Recent health care legislation in the United States has turned considerable focus to comparative effectiveness research (CER) domestically, though it has been a topic of discussion internationally for many years. Without a fully comprehensive and consistent definition of CER developed, much uncertainty and confusion surrounds its utilization. In addition, contention exists regarding the incorporation of cost and economic considerations as a component of CER. This discussion includes various suggested definitions of CER, methodological considerations, legislation and utilization, and the role of cost-effectiveness evaluations in CER.
KW - Comparative effectiveness research (CER)
KW - effectiveness
KW - health technology assessment
KW - outcomes
KW - pharmacoeconomics
UR - http://www.scopus.com/inward/record.url?scp=84856823973&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84856823973&partnerID=8YFLogxK
U2 - 10.3233/PPL-2011-0340
DO - 10.3233/PPL-2011-0340
M3 - Article
AN - SCOPUS:84856823973
VL - 14
SP - 27
EP - 35
JO - Pharmaceuticals Policy and Law
JF - Pharmaceuticals Policy and Law
SN - 1389-2827
IS - 1
ER -